Global beauty trend: 'vegetarian' makeup market expands

ACI expects healthcare antiseptic manufacturers to lose most active ingredients
The US Food and Drug Administration (FDA) will ban some 80% of active ingredients currently allowed for use in healthcare antiseptics, the American Cleaning Institute (ACI) expects.
Plans to require manufacturers to submit data demonstrating the safety and efficacy of their antibacterial ingredients were set out in a 2015 proposed rule - and are expected to become law when the final rule is issued. The FDA will assess data submitted by industry and decide whether to classify actives as "generally recognised as safe and effective" (Gras/Grae), or ban their use in the products.
Triclosana href='https://www.echemi.com/products/pid_Seven3714-triclocarban.html'>Triclocarban.
ACI expects triclosan to face a ban in healthcare products as well, along with more than 20 other ingredients, its associate vice president for environmental safety, Paul DeLeo, told CW+BiocidesHub.
Some substances will be banned due to a lack of support by industry, he said. "Companies know it won't get FDA approval so they are not willing to do the additional testing the agency is requiring."
Others will fail because the data to support them is too challenging to generate. The agency, he says, is asking for "new methods that we are not aware of anyone having successfully completed in this space", but it has been willing to give companies more time.
Looking for chemical products? Let suppliers reach out to you!
2026-06-22
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Lessons from Disco's Demise: Navigating the Complex Terrain of Men's Skincare
-
L'Oréal to Invest $80 Million in Mexico Factory Expansion
-
Unilever Reports Stronger Margins and Accelerated Portfolio Transformation in FY2025
-
Symrise Opens New Production Unit in Granada to Ensure Safer Supply of Bio-Based Pentylene Glycol
-
Henkel to Acquire Olaplex in $1.4 Billion Deal
-
DKSH Upgrades its Malaysia Innovation Center to Strengthen Technical Service Capabilities for the Southeast Asian Market
-
Procter & Gamble Posts Higher Profits on Strong Personal Care Sales and Recovery in China
-
Kao’s KANEBO Launches New Dual-Purpose Skincare Inspired by Vernix Caseosa, Ushering in a New Era of High-Performance Beauty
-
Azelis Partners with Sharon Personal Care in Colombia, Peru and Ecuador
-
HARKE GROUP Acquires Vendico Group, Strengthening Nordic Market leadership
Recommend Reading
-
Elkem Launches Innovative Formulations with Low-Cyclic Silicone Ingredients
-
Brenntag Partners with Givaudan to Supply Active Cosmetic Ingredients and Raw Materials to Thailand
-
Suave Brands and Elida Beauty Complete Merger to Form Personal Care Giant Evermark with Annual Retail Sales Near $1.9 Billion
-
Toray to Transfer Stake in Soda Aromatic to Samyang
-
Blackstone in Talks to Buy Juno Hair in South Korea for $590 Million
-
Global Food Policy Shift 60-Day Rice Import Ban in Philippines EU Issues 5 Recalls on Chinese Exports in One Week
-
Styrene-Butadiene Rubber Market Trends Slightly Down
-
Eli Lilly Strikes $1.3 Billion AI Deal with Superluminal for Next-Gen Obesity Drugs Targets GPCR Breakthrough
-
Recent EVA Market Trends Continue to Rise in China
-
Premium Global Chemical Sourcing Requests (11–15 Aug 2025)